Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

G6PD deficiency in Latin America: systematic review on prevalence and variants.

Monteiro WM, Val FF, Siqueira AM, Franca GP, Sampaio VS, Melo GC, Almeida AC, Brito MA, Peixoto HM, Fuller D, Bassat Q, Romero GA, Maria Regina F O, Marcus Vinícius G L.

Mem Inst Oswaldo Cruz. 2014 Aug;109(5):553-68. Epub 2014 Aug 19. Review.

2.

Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes.

Monteiro WM, Franca GP, Melo GC, Queiroz AL, Brito M, Peixoto HM, Oliveira MR, Romero GA, Bassat Q, Lacerda MV.

Malar J. 2014 Feb 25;13:70. doi: 10.1186/1475-2875-13-70. Review.

3.

Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.

Valencia SH, Ocampo ID, Arce-Plata MI, Recht J, Arévalo-Herrera M.

Malar J. 2016 May 26;15(1):291. doi: 10.1186/s12936-016-1343-1. Erratum in: Malar J. 2016;15(1):348.

4.

G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.

Dombrowski JG, Souza RM, Curry J, Hinton L, Silva NRM, Grignard L, Gonçalves LA, Gomes AR, Epiphanio S, Drakeley C, Huggett J, Clark TG, Campino S, Marinho CRF.

Malar J. 2017 Jun 15;16(1):253. doi: 10.1186/s12936-017-1889-6.

5.

G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.

Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI.

PLoS Med. 2012;9(11):e1001339. doi: 10.1371/journal.pmed.1001339. Epub 2012 Nov 13.

6.
7.

Spatial distribution of G6PD deficiency variants across malaria-endemic regions.

Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, Sakuntabhai A, Satyagraha AW, Williams TN, Baird JK, Hay SI.

Malar J. 2013 Nov 15;12:418. doi: 10.1186/1475-2875-12-418.

8.

Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.

Howes RE, Chan ER, Rakotomanga TA, Schulte S, Gibson J, Zikursh M, Franchard T, Ramiranirina B, Ratsimbasoa A, Zimmerman PA.

Malar J. 2017 Apr 4;16(1):139. doi: 10.1186/s12936-017-1771-6.

9.

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.

Kheng S, Muth S, Taylor WR, Tops N, Kosal K, Sothea K, Souy P, Kim S, Char CM, Vanna C, Ly P, Ringwald P, Khieu V, Kerleguer A, Tor P, Baird JK, Bjorge S, Menard D, Christophel E.

BMC Med. 2015 Aug 25;13:203. doi: 10.1186/s12916-015-0441-1.

10.

Glucose-6-phosphate dehydrogenase deficiency among malaria patients of Honduras: a descriptive study of archival blood samples.

Zúñiga MÁ, Mejía RE, Sánchez AL, Sosa-Ochoa WH, Fontecha GA.

Malar J. 2015 Aug 7;14:308. doi: 10.1186/s12936-015-0823-z.

11.

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.

Avalos S, Mejia RE, Banegas E, Salinas C, Gutierrez L, Fajardo M, Galo S, Pinto A, Mejia A, Fontecha G.

Malar J. 2018 Nov 8;17(1):415. doi: 10.1186/s12936-018-2564-2.

12.

Modelling primaquine-induced haemolysis in G6PD deficiency.

Watson J, Taylor WR, Menard D, Kheng S, White NJ.

Elife. 2017 Feb 4;6. pii: e23061. doi: 10.7554/eLife.23061.

13.

Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.

Ong KIC, Iwagami M, Araki H, Khattignavong P, Soundala P, Keomalaphet S, Prasayasith P, Lorpachan L, Xangsayalath P, Pongvongsa T, Hongvanthong B, Brey PT, Kano S, Jimba M.

Malar J. 2019 Mar 12;18(1):75. doi: 10.1186/s12936-019-2715-0.

14.

Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon.

Santana MS, Monteiro WM, Siqueira AM, Costa MF, Sampaio V, Lacerda MV, Alecrim MG.

Trans R Soc Trop Med Hyg. 2013 May;107(5):301-6. doi: 10.1093/trstmh/trt015. Epub 2013 Mar 10.

PMID:
23479361
15.

Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.

Tsegaye A, Golassa L, Mamo H, Erko B.

Malar J. 2014 Nov 18;13:438. doi: 10.1186/1475-2875-13-438.

16.

Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.

Shitaye G, Gadisa E, Grignard L, Shumie G, Chali W, Menberu T, Belachew M, Tegegn G, Challi S, Curry J, Mahey L, Hailu T, Mamo H, Menon M, Balcha T, Aseffa A, Drakeley C, Bousema T, Tadesse FG.

Malar J. 2018 Aug 2;17(1):281. doi: 10.1186/s12936-018-2437-8.

17.

The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children.

Okebe J, Amambua-Ngwa A, Parr J, Nishimura S, Daswani M, Takem EN, Affara M, Ceesay SJ, Nwakanma D, D'Alessandro U.

Malar J. 2014 Apr 17;13:148. doi: 10.1186/1475-2875-13-148.

18.

G6PD deficiency: global distribution, genetic variants and primaquine therapy.

Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI.

Adv Parasitol. 2013;81:133-201. doi: 10.1016/B978-0-12-407826-0.00004-7. Review.

PMID:
23384623
19.

Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.

Roh ME, Oyet C, Orikiriza P, Wade M, Mwanga-Amumpaire J, Boum Y 2nd, Kiwanuka GN, Parikh S.

Am J Trop Med Hyg. 2016 Nov 2;95(5):1094-1099. Epub 2016 Sep 26.

20.

Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.

Peixoto HM, Brito MA, Romero GA, Monteiro WM, de Lacerda MV, de Oliveira MR.

Malar J. 2016 Feb 11;15:82. doi: 10.1186/s12936-016-1140-x.

Supplemental Content

Support Center